Par Drugs and Chemicals Limited

NSE:PAR.NS

302.6 (INR) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 187.824-366.539366.539-298.54298.54-222.43222.43-193.798193.798-162.064162.064-179.107179.107-211.638211.638132.225-73.79273.79273.79272.99772.9970.3060.3060.1520.152
Short Term Investments 0733.07831.306597.080444.8630.016387.5960324.12810.016358.2140423.27600147.58300000000
Cash and Short Term Investments 187.824366.539366.539298.54298.54222.43222.43193.798193.798162.064162.064179.107179.107211.638211.638132.22573.79273.79273.79272.99772.9970.3060.3060.1520.152
Net Receivables 229.8470138.090171.0740218.1510239.8270217.3740141.6410170.25156.5940139.225123.684131.323124.21298.55985.197123.931123.931
Inventory 49.344041.77041.739053.79045.308047.127029.892029.96726.105029.16834.90631.33531.33542.94248.94343.79443.794
Other Current Assets 23.622049.837029.1410-0.00107.68609.074032.972008.3880-09.8034.73811.8490.0357.3952.3352.335
Total Current Assets 490.637366.539596.236298.54540.494222.43494.37193.798486.619162.064435.639179.107383.612211.638411.855323.31273.792242.185242.185240.393240.393141.842141.84170.212170.212
Non-Current Assets:
Property, Plant & Equipment, Net 401.2770413.3490409.6520386.9450354.9330343.5140343.9260343.709340.9430351.352351.352338.338338.338363.41363.41378.084378.084
Goodwill 0000000000000000000000000
Intangible Assets 0000000000000000000000000
Goodwill and Intangible Assets 00-0.4000-0.7000-2.80100000000000000
Long Term Investments 258.64600.11900.100.100.101.60100.100.10.66500.5650.5650.5650.5650.5650.5650.5650.565
Tax Assets 000.40000.70001.200000000000000
Other Non-Current Assets 5.989-366.5396.407-298.546.304-222.437.264-193.7987.696-162.0647.749-179.1077.945-211.6388.1767.806-73.7927.057.057.8757.8747.7396.8587.6487.648
Total Non-Current Assets 665.912-366.539419.875-298.54416.056-222.43394.309-193.798362.729-162.064351.263-179.107351.971-211.638351.986349.414-73.792358.967358.967346.778346.777371.714370.833386.297386.297
Total Assets 1,156.54901,016.1110956.550888.6790849.3480786.9020735.5830763.841672.7260601.152601.152587.171587.17513.555512.673556.509556.509
Liabilities & Equity:
Current Liabilities:
Account Payables 107.589053.5620100.746080.915078.9990106.618057.858067.17871.173062.04562.04569.55169.55149.31849.31872.90272.902
Short Term Debt 00-0.051000-0.623036.1820-0.0900039.2940013.92513.9250055.49655.49476.76876.768
Tax Payables 0049.7560000000000000000000000
Deferred Revenue 000.0510000.623020.24400.0900046.5280029.98200016.468000
Other Current Liabilities 45.951070.829032.239058.979014.901041.956031.62906.79261.24702.48932.47126.89226.8923.27419.74420.65120.651
Total Current Liabilities 153.540124.3910132.9850139.8940150.3260148.574089.4870159.792132.420108.442108.44296.44396.443124.556124.557170.321170.321
Non-Current Liabilities:
Long Term Debt 00000000000039.619043.91843.335046.19146.19161.03961.03960.31360.314127.661127.661
Deferred Revenue Non-Current 0000000000000003.8620003.26903.269000
Deferred Tax Liabilities Non-Current 35.4035.4035035035.5035.5034.051034.05135.854036.512035.075034.243000
Other Non-Current Liabilities 0-856.32-002.58801.40204.5604.05603.52503.9350.00103.86240.3740.00238.3440.00137.51337.86437.864
Total Non-Current Liabilities 35.4-856.3235.4037.588036.402040.06039.556077.195081.90383.052086.56586.56599.38599.38397.82697.827165.525165.525
Total Liabilities 188.94-856.32159.7910170.5730176.2960190.3860188.130166.6820241.695215.4720195.007195.007195.828195.826222.382222.383335.846335.846
Equity:
Preferred Stock 0000000000000000000000057.557.5
Common Stock 123.0460123.0460123.0460123.0460123.0460123.0460123.046061.52361.523061.52361.52361.52361.52344.80344.8032727
Retained Earnings 00625.512000481.575000367.964000291.33700175.337175.68700145.637145.103135.477135.477
Accumulated Other Comprehensive Income/Loss 0856.32733.274785.977662.931712.3831.036658.963535.917598.7721.036568.901445.855522.1450.686395.732406.1450.6860.686329.821329.8210.6860.6860.6860.686
Other Total Stockholders Equity 844.5630-625.512000106.7260-0.0010106.726000168.599-0.0010168.599168.249-0.0010100.04799.69700
Total Shareholders Equity 967.609856.32856.32785.977785.977712.383712.383658.963658.962598.772598.772568.901568.901522.145522.145457.254406.145406.145406.145391.343391.344291.173290.289220.663220.663
Total Equity 967.609856.32856.32785.977785.977712.383712.383658.963658.962598.772598.772568.901568.901522.145522.145457.254406.145406.145406.145391.343391.344291.173290.289220.663220.663
Total Liabilities & Shareholders Equity 1,156.549856.321,016.111785.977956.55712.383888.679658.963849.348598.772786.902568.901735.583522.145763.841672.726406.145601.152601.152587.171587.17513.555512.673556.509556.509